REGEN BIOPHARMA, INC. (RGBPP) Operating cash flow 2017–2025
REGEN BIOPHARMA, INC. (RGBPP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$383,591FY2025 · since FY2017: -$1.9M → -$383,591
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383,591 | +49.0% |
| FY2024 | -$751,536 | -332.1% |
| FY2023 | -$173,917 | +71.3% |
| FY2022 | -$606,921 | +46.3% |
| FY2021 | -$1.1M | -6165.6% |
| FY2020 | $18,645 | +103.9% |
| FY2019 | -$481,792 | +69.5% |
| FY2018 | -$1.6M | +16.7% |
| FY2017 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGBPP financial trends
RGBPP RevenueRGBPP Net incomeRGBPP Net marginRGBPP Gross profitRGBPP Gross marginRGBPP Operating incomeRGBPP Operating marginRGBPP Free cash flowRGBPP Capital expendituresRGBPP Return on equityRGBPP Stock buybacksRGBPP Dividends paidRGBPP Total assetsRGBPP Total liabilitiesRGBPP Shareholders’ equityRGBPP overview →